OCRIPLASMIN FOR VITREOMACULAR TRACTION IN CLINICAL PRACTICE: The INJECT Study

PURPOSE: Randomized clinical trials have demonstrated the safety and efficacy of ocriplasmin in patients with vitreomacular traction (VMT), including those with macular hole (MH). The INJECT study prospectively evaluated ocriplasmin in the setting of clinical practice. METHODS: INJECT was a Phase 4,...

Descripción completa

Detalles Bibliográficos
Autores principales: Steel, David H. W., Patton, Niall, Stappler, Theodor, Karia, Niral, Hoerauf, Hans, Patel, Nishal, Wachtlin, Joachim, Raber, Thomas, Kozma-Wiebe, Petra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Retina 2020
Materias:
Original Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7819525/
https://www.ncbi.nlm.nih.gov/pubmed/32496343
http://dx.doi.org/10.1097/IAE.0000000000002862

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7819525/
https://www.ncbi.nlm.nih.gov/pubmed/32496343
http://dx.doi.org/10.1097/IAE.0000000000002862

Ejemplares similares